Development of Mental Health Prescription Decision Support with Pharmacogenetics

Description
Prescribing medications for mental health remains a challenge. In an effort to use unbiased biological data to improve prescribing in mental health, RxRevu partnered with the Mental Health Center of Denver and was awarded a Phase I Small Business Innovation Research grant from the National Institute of Mental Health (NIMH) to develop a software tool that converts a patient's pharmacogenetic test results into a digestible/machine readable format, and incorporates mental health provider preferences into a user interface that serves as a one-stop view in the Electronic Health Record for mental health providers to make the most up-to-date and informed decisions about what medications they select for their patients.
Start Date
4/5/2017
Projected End Date
4/4/2018
Project Tags
  • FHIR
  • CCDA
  • Mental Health
  • Behavioral Health
  • Colorado
  • RxRevu
  • MHCD
  • HIT Vendor
  • Pharmacogenetics
  • PGx
  • EHR Integration
  • NIMH
Project Point of Contact: weston.blakesleeremove@removerxrevu.com
Project Results
None